Research Articles | Page 12 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study Jun 2023 American Journal of Hematology Aplastic Anemia
Raising the bar for lower-risk myelodysplastic syndromes Jun 2023 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations Jun 2023 Advances in Therapy Paroxysmal Nocturnal Hemoglobinuria (PNH)
Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes Jun 2023 European Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery? Jun 2023 Leukemia & Lymphoma Aplastic Anemia
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Therapy-related myelodysplastic syndromes in the genomics era Jun 2023 Bulletin du Cancer Myelodysplastic Syndromes (MDS)
Treatment of eculizumab refractory paroxysmal nocturnal hemoglobinuria: A systematic review about current treatment options and future direction Jun 2023 SAGE Open Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)